Director Michael L. Steiner of Vireo Growth Inc. filed a Form 4 on November 4, 2026, disclosing the acquisition of stock options and restricted stock units on November 3, 2026.
Director Linda T. Hollembaek filed a Form 4 with the SEC on November 4, 2026, reporting the sale of 1,315 shares of Manhattan Associates Inc common stock on November 3, 2026.
Director Rainer Gawlick filed a Form 4 with the SEC on November 4, 2026, disclosing a purchase of Proto Labs Inc common stock on November 3, 2026.
Proto Labs Inc President and CEO Suresh Krishna filed a Form 4 on November 4, 2026, disclosing an open-market purchase of 750 shares of Proto Labs common stock on November 2, 2026.
Jeffrey Bertolini, Chief Operating Officer of Carlsmed, Inc. (NASDAQ:CARL), filed a Form 4 on November 4, 2026, disclosing a stock option exercise and same-day sale of 747 shares of common stock on November 3, 2026.
Jandeen M. Boone, Executive Vice President, General Counsel and Secretary of Ecolab Inc., filed a Form 4 on November 4, 2026, disclosing the vesting of 1,769 restricted stock units on November 2, 2026, and a subsequent withholding of shares to satisfy minimum statutory tax …
Bryce L. Mewhorter, SVP and Corporate Controller of Ecolab Inc., filed a Form 4 on November 4, 2026, reporting the vesting of restricted stock units and a related share withholding transaction dated November 2, 2026.
Ecolab Inc. EVP of Global Supply Chain Benjamin M. Clark filed a Form 4 on November 4, 2026, disclosing the vesting of 8,843 restricted stock units and a related share withholding transaction dated November 2, 2026.
Luke Roy Swanson, Chief Technology Officer of Ibotta, Inc. (NASDAQ:IBTA), filed a Form 4 on November 4, 2026, disclosing sales of Class A Common Stock on November 2 and November 3, 2026, executed under a Rule 10b5-1 trading plan.
Gary B. Smith, President and CEO of Ciena Corp, filed a Form 4 on November 4, 2026, disclosing the sale of 2,952 shares of Ciena common stock on November 2, 2026, under a Rule 10b5-1 trading plan.